Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 21301-21350 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT07007299
Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident
N/A
Recruiting
1,500 participants
Started: Jul 17, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
4 locations
NCT06984445
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
N/A
Recruiting
180 participants
Started: Jul 17, 2024 · Completed: Apr 30, 2026
4 conditions
1 sponsor
1 location
NCT05108870
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
PHASE1/PHASE2
Recruiting
98 participants
Started: Jul 17, 2024 · Completed: Jan 1, 2026
4 conditions
1 sponsor
1 location
NCT06325852
Directional Bilateral Thalamic Patterned Stimulation (Chronos)
NA
Recruiting
15 participants
Started: Jul 16, 2024 · Completed: Jan 1, 2027
1 condition
2 sponsors
1 location
NCT06814470
Virtual Reality Guided Acupuncture Imagery Treatment for Chronic Low Back Pain
NA
Recruiting
30 participants
Started: Jul 16, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06161441
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
PHASE2
Recruiting
180 participants
Started: Jul 16, 2024 · Completed: Apr 19, 2029
1 condition
1 sponsor
124 locations
NCT06341413
Sleep and Emotion Processing in Adolescent Post-traumatic Stress Disorder
NA
Recruiting
180 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT06487858
A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
PHASE1
Recruiting
74 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
8 locations
NCT06506656
Hyaluronic Acid and Adelmidrol (Hyadrol®) in Patients With Degenerative Joint Disease
NA
Recruiting
59 participants
Started: Jul 16, 2024 · Completed: Jul 31, 2025
1 condition
2 sponsors
1 location
NCT06439875
Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation.
NA
Recruiting
102 participants
Started: Jul 16, 2024 · Completed: Apr 30, 2026
2 conditions
3 sponsors
3 locations
NCT06531278
Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
PHASE2
Recruiting
40 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06465303
A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)
PHASE2
Recruiting
96 participants
Started: Jul 16, 2024 · Completed: Dec 21, 2025
1 condition
1 sponsor
1 location
NCT06448572
EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.
PHASE1/PHASE2
Recruiting
21 participants
Started: Jul 16, 2024 · Completed: Oct 1, 2028
1 condition
2 sponsors
1 location
NCT07111195
Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
N/A
Recruiting
140 participants
Started: Jul 16, 2024 · Completed: Sep 30, 2026
1 condition
6 sponsors
5 locations
NCT06498752
MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
PHASE2
Recruiting
102 participants
Started: Jul 16, 2024 · Completed: Jun 30, 2025
1 condition
4 sponsors
1 location
NCT06456346
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
PHASE3
Recruiting
300 participants
Started: Jul 16, 2024 · Completed: Apr 15, 2029
1 condition
1 sponsor
137 locations
NCT06466525
A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.
PHASE1
Recruiting
64 participants
Started: Jul 16, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT06248723
ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults
NA
Recruiting
1,340 participants
Started: Jul 16, 2024 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT07131163
Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection
N/A
Recruiting
60 participants
Started: Jul 16, 2024 · Completed: Dec 30, 2025
1 condition
11 sponsors
1 location
NCT06437574
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
PHASE2
Recruiting
140 participants
Started: Jul 16, 2024 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT06449638
Modified Platform Trial Assessing Multiple CAMPs and SOC Vs SOC Alone in the Treatment of Hard-to-Heal DFUs
NA
Recruiting
272 participants
Started: Jul 16, 2024 · Completed: Aug 31, 2026
4 conditions
2 sponsors
5 locations
NCT06439381
Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps
PHASE2
Recruiting
120 participants
Started: Jul 16, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
28 locations
NCT05855746
Colchicine Versus Placebo in Acute Myocarditis Patients
PHASE3
Recruiting
300 participants
Started: Jul 16, 2024 · Completed: Jul 16, 2028
1 condition
3 sponsors
2 locations
NCT05485766
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
PHASE2
Recruiting
23 participants
Started: Jul 16, 2024 · Completed: Sep 30, 2028
8 conditions
2 sponsors
3 locations
NCT06411210
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
PHASE2
Recruiting
54 participants
Started: Jul 16, 2024 · Completed: Jun 30, 2028
2 conditions
3 sponsors
1 location
NCT05952024
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
PHASE2
Recruiting
80 participants
Started: Jul 16, 2024 · Completed: Aug 24, 2027
1 condition
1 sponsor
53 locations
NCT06613256
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
N/A
Recruiting
105 participants
Started: Jul 16, 2024 · Completed: Nov 12, 2026
2 conditions
2 sponsors
1 location
NCT06427876
Fasenra Pediatric Japan Post-Marketing Study(PMS)
N/A
Recruiting
40 participants
Started: Jul 16, 2024 · Completed: Mar 17, 2027
1 condition
1 sponsor
11 locations
NCT06413355
FAPI-74 PET/CT in Adults with Fibrosis
PHASE1
Recruiting
45 participants
Started: Jul 16, 2024 · Completed: Jul 30, 2027
1 condition
1 sponsor
1 location
NCT06392776
Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL
NA
Recruiting
420 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2029
2 conditions
1 sponsor
4 locations
NCT06954272
Characterisation of Skin Microstructure Under Normal and Atrophied States
N/A
Recruiting
180 participants
Started: Jul 16, 2024 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT06791226
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NA
Recruiting
50 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06504290
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
PHASE1
Recruiting
40 participants
Started: Jul 16, 2024 · Completed: Dec 1, 2025
1 condition
1 sponsor
4 locations
NCT07103980
Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial
PHASE1/PHASE2
Recruiting
40 participants
Started: Jul 16, 2024 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT06449521
BECOME COmbined Intervention for MH & NCD Delivered by Community Health Workers in Nepal
NA
Recruiting
700 participants
Started: Jul 16, 2024 · Completed: Apr 30, 2028
2 conditions
4 sponsors
1 location
NCT06616753
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
N/A
Recruiting
140 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06389721
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
N/A
Recruiting
45 participants
Started: Jul 16, 2024 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT05784038
Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
N/A
Recruiting
80 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2026
2 conditions
2 sponsors
3 locations
NCT06474832
High Intensity Interval Training in Chronic Stroke
NA
Recruiting
32 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06203847
The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA
NA
Recruiting
1,274 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2026
3 conditions
1 sponsor
2 locations
NCT06427395
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
PHASE3
Recruiting
150 participants
Started: Jul 16, 2024 · Completed: Jul 18, 2027
1 condition
1 sponsor
41 locations
NCT06455995
Daily Eating Patterns for Total Health Study
NA
Recruiting
174 participants
Started: Jul 16, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT07193823
Sexual Dysfunction in Women With Multiple Sclerosis (MS)
N/A
Recruiting
140 participants
Started: Jul 16, 2024 · Completed: Nov 30, 2025
9 conditions
1 sponsor
1 location
NCT06536127
Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer
NA
Recruiting
100 participants
Started: Jul 16, 2024 · Completed: Jul 30, 2028
2 conditions
1 sponsor
1 location
NCT06501014
Effectiveness of Action Observation Therapy in Stroke Patients
NA
Recruiting
40 participants
Started: Jul 16, 2024 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT06128070
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
PHASE2
Recruiting
40 participants
Started: Jul 16, 2024 · Completed: Nov 22, 2030
3 conditions
2 sponsors
1 location
NCT05466929
Engagement With Digital Mental Health (DMH) Technologies in Pediatric Primary Care
NA
Recruiting
300 participants
Started: Jul 16, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
2 locations
NCT06276374
Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients
NA
Recruiting
1,556 participants
Started: Jul 15, 2024 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT06455969
Adaptions and Resiliency to Multi-Stressor OpeRations
PHASE4
Recruiting
120 participants
Started: Jul 15, 2024 · Completed: Aug 1, 2026
2 conditions
2 sponsors
1 location
NCT06393530
Erector Spinae Plane Block for Cervical Spine Surgery
PHASE4
Recruiting
60 participants
Started: Jul 15, 2024 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
Previous
1
More pages
424
425
426
427
428
429
430
More pages
1333
Next